sulcef 2 g
medochemie ltd., cyprus - cefoperazón, kombinácie - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
suxamethonium chlorid vuab 250 mg
vuab pharma a.s., Česká republika - suxametónium - 63 - myorelaxantia
sarclisa
sanofi winthrop industrie - isatuximab - viacnásobný myelóm - antineoplastické činidlá - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
xonvea 10 mg/10 mg gastrorezistentné tablety
exeltis slovakia s.r.o., slovensko - doxylamín,kombinácie - 20 - antiemetica, antivertiginosa
xonvea 20 mg/20 mg tablety s riadeným uvoľňovaním
exeltis slovakia s.r.o., slovensko - doxylamín,kombinácie - 20 - antiemetica, antivertiginosa